CSI Market
Sign In | Register

Genocea Biosciences Inc (GNCA) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access GNCA Annual Income Statement →
From Genocea Biosciences Inc through Mar 31 2021, changes in Mar 31 2022's revenue and cost structure provide insight into profitability trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2022)
Q1 2022 		(Dec 31 2021) (Sep 30 2021) (Jun 30 2021) (Mar 31 2021)
Revenues
Revenue From Contract With Customer Including Assessed Tax0.27
Total Revenue0.27
Costs & Expenses
Gross Profit0.27
Selling, Administration, Marketing3.60
Depreciation & Amortization0.40
Research and Development Expense12.44
Other Operating Expense / -Income0.00
Total operating costs including COS16.04
Operating income / -loss-15.77
Interest Expense0.00
Interest Expense, Borrowings0.20
Net Interest Expense / -Income0.00
Other loss / -income0.21
Total costs & expenses16.25
Income & Taxes
Income / -loss before income taxes-15.98
Income after income taxes-15.98
Income / -loss from continuing operations-15.98
Preferred dividends0.00
Net income / -loss-15.98
Income / -loss to shareholder-15.98
EBIT-15.98
EBITD-15.58
EBITDA-15.47
Earnings Per Share
Basic EPS (excl. extra items)-0.22
Basic Net EPS-0.22
Basic shares outstanding (Mill. of Units)71.12
Diluted Net EPS-0.22
Diluted average shares (Mill. of Units)71.12
4 historic quarters locked

Sign in to unlock the full Genocea Biosciences Inc income statement history.

Sign In Create Free Account

About GNCA Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.